低密度脂蛋白和高密度脂蛋白亚类鉴定在乙型肝炎病毒相关性肝癌发生风险预测中的意义

doi:10.3969/j.issn.1005-6483.2022.09.020

临床外科杂志 ›› 2022, Vol. 30 ›› Issue (9): 875-879.doi: 10.3969/j.issn.1005-6483.2022.09.020

低密度脂蛋白和高密度脂蛋白亚类鉴定在乙型肝炎病毒相关性肝癌发生风险预测中的意义

430065 武汉科技大学公共卫生学院(罗恒、卫向红)；武汉科技大学临床学院(吴清明) ;武汉科技大学基础医学院(向世强)；空军军医大学第一附属医院肝胆胰脾外科(张若涵)

收稿日期:2021-06-07 接受日期:2021-06-07 出版日期:2022-09-20 发布日期:2022-10-14
通讯作者: 卫向红，Email：996079380@qq.com
基金资助:
国家自然科学基金项目(81702329)

Significance of identification of low-density lipoprotein and high-density lipoprotein subclasses in the risk prediction of HBV-related liver cancer

School of Public Health,Wuhan University of Science and Technology,Wuhan 430065,China

Received:2021-06-07 Accepted:2021-06-07 Online:2022-09-20 Published:2022-10-14

摘要/Abstract

摘要： 目的探讨低密度脂蛋白(LDL)和高密度低脂蛋白(HDL)亚类鉴定在乙型肝炎病毒(HBV)相关性肝癌发生风险预测中的临床意义。方法 2017年1月~12月，前瞻性纳入90例在空军军医大学第一附属医院接受诊断和治疗的HBV携带者，分为肝癌组(n=30)、肝硬化组(n=30)和慢性肝病组(n=30)。聚丙烯酰胺凝胶电泳分析血清LDL亚类，血清HDL亚类通过二维凝胶电泳和免疫印迹法确定。比较各组临床资料和血清LDL、HDL亚类水平，Logistic模型分析影响肝癌发生风险的危险因素。受试者工作特征(ROC)曲线分析各指标的预测效能。结果与慢性肝炎组比较，肝硬化组和肝癌组患者血清小而密LDL(sdLDL)水平显著上升，同时血清HDL2、HDL3水平显著降低，均P<0.05。且肝癌组患者血清sdLDL水平高于肝硬化组，血清HDL2、HDL3水平低于肝硬化组，均P<0.05。经Logistic回归分析，血清sdLDL水平上升、HDL3水平下降是影响慢性肝病患者发生肝癌的独立危险因素，P<0.05。经ROC曲线分析，血清sdLDL、HDL3预测肝癌发生的曲线下面积为0.899(0.835~0.964)、0.816(0.731～0.902)，特异度0.883、0.976，灵敏度0.867、0.600。结论血清sdLDL和HDL3水平与HBV相关性肝癌的发生风险有关，监测血清sdLDL和HDL3水平有助于肝癌的早期诊断。

关键词: 低密度脂蛋白, 高密度脂蛋白, 肝癌, sdLDL

Abstract: Objective To explore the clinical significance of identification of low-density lipoprotein(LDL) and highd-ensity low lipoprotein(HDL) subclasses in the risk prediction of hepatitis B virus(HBV)-related liver cancer.Methods From January to December 2017,90 HBV carriers diagnosed and treated in the First Affiliated Hospital of the Air Force Military Medical University were prospectively included,and they were divided into liver cancer group(n=30),liver cirrhosis group(n=30) and chronic liver disease group(n=30).Serum LDL subtypes were analyzed by polyacrylamide gel electrophoresis,and serum HDL subtypes were determined by two-dimensional gel electrophoresis and western blotting.The clinical data of each group and the levels of serum LDL and HDL subtypes were compared,and the risk factors affecting the occurrence and prognosis of liver cancer were analyzed by Logistic regression model.The predictive efficacy of each index was analyzed by the receiver operating characteristic(ROC) curve.〖WTHZ〗Results Compared with the chronic hepatitis group,Small and dense(sd) LDL levels in patients with liver cirrhosis and liver cancer increased significantly,and serum HDL2 and HDL3 levels decreased significantly,both P<0.05.In addition,the serum sdLDL level of the liver cancer group was higher than that of the liver cirrhosis group,and the serum HDL2 and HDL3 levels were lower than that of the liver cirrhosis group,both P<0.05.Logistic regression analysis showed that the increase of serum sdLDL level and the decrease of HDL3 level are independent risk factors of liver cancer in patients with chronic liver disease,P<0.05.After ROC curve analysis,the area under the curve of serum sdLDL and HDL3 predicting the occurrence of liver cancer was 0.899(0.835~0.964) and 0.816(0.731~0.902),the specificities were 0.883,0.976,the sensitivities were 0.867,0.600.Conclusion Serum sdLDL and HDL3 levels are related to the risk of HBV-related liver cancer.Monitoring serum sdLDL and HDL3 levels is helpful for early diagnosis of liver cancer.

Key words: low-density lipoprotein, high-density lipoprotein, liver cancer, sdLDL

罗恒卫向红吴清明向世强张若涵. 低密度脂蛋白和高密度脂蛋白亚类鉴定在乙型肝炎病毒相关性肝癌发生风险预测中的意义[J]. 临床外科杂志, 2022, 30(9): 875-879.

LUO Heng, WEI Xianghong, WU Qingming, et al. Significance of identification of low-density lipoprotein and high-density lipoprotein subclasses in the risk prediction of HBV-related liver cancer[J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(9): 875-879.

参考文献

相关文章 15

[1]	杨刚王冠熊永福李芸雷蓉柳弥. 肝癌调控细胞凋亡抑制因子1的表达及其对细胞增殖和凋亡的影响[J]. 临床外科杂志, 2022, 30(5): 471-474.
[2]	蔡秀军张斌陈鸣宇曹佳胜. 美国国家综合癌症网络肝胆肿瘤临床实践指南2021.V2版更新解读(肝癌部分)[J]. 临床外科杂志, 2022, 30(1): 4-6.
[3]	李江, 陈耀兵, 陈丽君等. 自体肿瘤浸润淋巴细胞联合抗程序性死亡受体1单抗治疗晚期肝癌的临床研究[J]. 临床外科杂志, 2021, 29(8): 743-747.
[4]	孙启刚, 符策雄, 郑进方. 绕肝悬吊前入路右半肝切除术在肝癌手术中的应用研究[J]. 临床外科杂志, 2021, 29(8): 748-750.
[5]	潘乐玉, 郭德良, 张玉仙等. 肝动脉结扎联合门静脉部分阻断对肝再生及肝细胞癌生长的影响[J]. 临床外科杂志, 2021, 29(4): 367-371.
[6]	王观宇. 肝癌转化治疗的策略和现状[J]. 临床外科杂志, 2021, 29(11): 1012-1014.
[7]	方小三王小明韩婷蒋彬王冠男奚士航. 原发性肝癌病人腹腔镜肝叶切除术后并发胆漏的风险预测模型构建[J]. 临床外科杂志, 2021, 29(11): 1030-1033.
[8]	李柱威尹东亮黎笑兰王金林林志强卢沛林尹润龙. 预存式自体输血对肝癌手术病人炎症反应及免疫功能的影响[J]. 临床外科杂志, 2021, 29(11): 1034-1037.
[9]	郭张有洪源. 肝硬化门静脉高压症肝癌手术切除全程评估和管理的进展[J]. 临床外科杂志, 2021, 29(11): 1092-1095.
[10]	郭杨韩磊常轶群吴军张巍. 原发性肝癌合并先天性右侧膈肌缺损行肝部分切除术一例[J]. 临床外科杂志, 2021, 29(11): 1099-1100.
[11]	国际肝胆胰协会中国分会全国肝病和肝癌大数据联盟. 原发性肝癌临床标准化术语[J]. 临床外科杂志, 2020, 28(8): 722-724.
[12]	鲍伟. 功能性残余肝脏体积与脾脏体积比对病人术后肝功能不全以及肝功能恢复的预测价值[J]. 临床外科杂志, 2020, 28(8): 750-752.
[13]	黄志勇, 陈孝平. 肝硬化与肝癌肝切除的科学决策[J]. 临床外科杂志, 2019, 27(8): 631-633.
[14]	张海峰, 宋栋达, 刘荣. 达芬奇机器人右半肝切除技巧与经验[J]. 临床外科杂志, 2019, 27(8): 634-637.
[15]	肖永胜, 周俭. 肝移植术后肝癌复发转移与PD-1/PD-L1抑制剂免疫治疗[J]. 临床外科杂志, 2019, 27(8): 642-645.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

低密度脂蛋白和高密度脂蛋白亚类鉴定在乙型肝炎病毒相关性肝癌发生风险预测中的意义

Significance of identification of low-density lipoprotein and high-density lipoprotein subclasses in the risk prediction of HBV-related liver cancer

PDF (PC)

PDF (Mobile)

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 10